HSCLC COMPANY LIMITED

Company number 13909894 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

HSCLC COMPANY LIMITED - Analysis Report

Company Number: 13909894

Analysis Date: 2025-07-20 13:50 UTC

Financial Health Assessment for HSCLC COMPANY LIMITED
Financial Year Ended 31 March 2024


1. Financial Health Score: C

Explanation:
HSCLC COMPANY LIMITED's financial health is currently rated a C, indicating a mixed condition with significant warning signs but also some positive attributes. The company shows strong net asset value due to substantial fixed asset investments, yet it exhibits symptoms of liquidity stress reflected by negative working capital and a heavy reliance on creditor funding. This suggests that while the company has a solid asset base, its short-term cash flow and ability to meet immediate obligations are strained.


2. Key Vital Signs

Metric 2024 Value Interpretation
Fixed Assets (Investments) £1,027,675 Strong asset base, mainly investments in subsidiaries or associates, indicating long-term value.
Current Assets £258 Extremely low liquid assets available to cover short-term liabilities.
Cash on Hand £183 Very limited cash reserves, indicating tight liquidity.
Debtors £75 Minimal receivables, suggesting limited incoming short-term cash flow.
Current Liabilities £216,116 High short-term obligations, potentially putting pressure on liquidity.
Net Current Assets (Working Capital) -£215,858 Negative working capital, a symptom of liquidity distress. The company owes far more in the short term than it can currently cover with liquid assets.
Net Assets (Shareholders’ Funds) £811,817 Positive equity showing the company has accumulated value and is not insolvent.
Change in Net Assets (2023-2024) +£88,037 Growth in net assets, signaling some improvement or retained earnings.

3. Diagnosis

HSCLC COMPANY LIMITED resembles a patient with a strong skeletal frame (fixed assets/investments) but weak blood circulation (cash and working capital). The company's investments of over £1 million form a healthy core asset foundation, indicating it holds valuable subsidiaries or associate companies. However, the current asset level of just £258 against current liabilities exceeding £216,000 reveals a critical liquidity issue — like a patient with sufficient muscle mass but suffering from poor circulation, risking tissue starvation.

This negative working capital means the company may struggle to pay its bills on time, which could impair supplier relationships or credit terms. The reduction in current liabilities from £303,970 in 2023 to £216,116 in 2024 is a positive sign, showing an effort to manage short-term debt load. However, current liabilities still far exceed current assets, signaling ongoing cash flow stress.

The increase in net assets from £723,780 to £811,817 indicates that despite liquidity symptoms, the company remains solvent and is building equity. This suggests that the business model or underlying investments retain value and may generate future income or capital appreciation.

The company employs 7 staff on average, which is consistent with a small enterprise structure. The directors’ professional background (solicitors) and the company’s SIC code (64209 – activities of other holding companies) indicate it operates primarily as a holding company, meaning its operational cash flow may be limited, relying on dividends or returns from subsidiaries.


4. Recommendations

  • Improve Liquidity (Circulation Boost):
    The company needs to focus on increasing liquid assets to cover short-term liabilities better. This could involve negotiating longer payment terms with creditors, accelerating receivables collection, or injecting additional working capital through shareholder loans or equity.

  • Monitor and Manage Working Capital Closely:
    Regular cash flow forecasting and tight control over payables and receivables will help prevent liquidity crises. Consider short-term financing options like overdrafts or invoice financing as a buffer.

  • Assess Investment Performance (Asset Health Check):
    Since fixed assets are primarily investments, ensure these subsidiaries or associates are generating sufficient returns or dividends to support the holding company’s cash needs. If any investments are underperforming, consider restructuring or divestment.

  • Plan for Sustainability:
    The current setup may be sustainable if the holding company receives steady income from subsidiaries, but the negative working capital poses a risk. Developing a plan to build cash reserves over the next 12 months will strengthen financial resilience.

  • Transparency and Compliance:
    Maintain timely filing of accounts and confirmation statements (which the company currently does), to avoid penalties and preserve stakeholder confidence.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.